investordatabase.org

Samsara BioCapital, LLC

samsaracap.com Direct investor

Samsara BioCapital is a venture capital firm that invests in biotechnology and therapeutic companies. It focuses on creating transformative therapeutics and partners with scientists and entrepreneurs.

Samsara BioCapital, LLC is a venture capital firm headquartered in Palo Alto, United States, founded in 2017. It invests directly in companies, from Series A to Series C and later, in biotech, therapeutics and life sciences.

“Investing to create transformative therapeutics for patients.”

Samsara BioCapital, LLC, own website
Layer
Direct investor
Type
Venture capital
Stage
Series ASeries C+
Headquarters
Palo Alto, United States
Invests in
US
Sectors
biotech, therapeutics, life sciences
Founded
2017

Team, as Samsara BioCapital, LLC publishes it

  • Srini Akkaraju Founder & Managing Partner
  • Mike Dybbs Partner
  • Abe Bassan Partner
  • Mitchell Mutz Senior Principal
  • Matt Eckler Principal, Public Investing
  • Jake Bieber-Dishart Senior Associate
  • Clara Dong Senior Associate
  • Ehi Akhirome Senior Associate
  • Jim P. Edwards Venture Partner
  • David Parry Venture Partner
  • Ravi Rao Venture Partner

Names and roles exactly as listed on samsaracap.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 39 co-investors found.

and 29 more — the graph.

Where this comes from

Every fact above was read from a page Samsara BioCapital, LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 4916 · added 2026-09-03 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under